ARCHIVES

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

This article is from The Cancer Letter archive.

Vol. 20 No. 26 | July 1, 1994

Download PDF Visit The Full Archive

Related Articles

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

December 16, 1977

Sentinel Node Disection No Worse Than Axillary

February 25, 2011

Funding opportunities listed.

June 18, 2004